Citigroup
RNVA

Citigroup’s Rennova Health, Inc. RNVA Stock Holding History

Citigroup’s Portfolio RNVA Stock Details RNVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-8
Closed – – 7631
2017
Q1 		$0 Hold
8
– – ﹤0.01% 7459
2016
Q4 		$0 Buy
+8
New +$454 ﹤0.01% 7443
2016
Q2 		– Hold
0
– – – 7719
2016
Q1 		– Sell
-1
Closed -$367 – 8016
2015
Q4 		$0 Buy
+1
New +$1.73K ﹤0.01% 8095
2015
Q2 		– Hold
0
– -$1K – 7946
2015
Q1 		– Hold
0
– – – 7124
2014
Q4 		– Hold
0
– – – 7483
2014
Q1 		– Hold
0
– -$1K – 7337
2013
Q4 		– Hold
0
– – – 6911

Other funds holding RNVA

VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citigroup's RNVA Position: Q2 2017 in Review

Citigroup sold out of Rennova Health, Inc. (RNVA) in Q2 2017, closing a stake of 8 shares.

Citigroup first reported a position in RNVA in Q4 2015 and held it in 3 quarters. The position peaked at $0 in Q1 2017. 8 funds tracked by Wall St. Rank hold RNVA as of Q2 2017.

  • Citigroup reported no remaining Rennova Health, Inc. position as of Q2 2017 after selling out during the quarter.
  • Citigroup sold 8 Rennova Health, Inc. shares in Q2 2017.
  • Citigroup first reported a position in Rennova Health, Inc. in Q4 2015 and held it in 3 quarters.
  • Citigroup's Rennova Health, Inc. position peaked at $0 in Q1 2017.
  • 8 funds tracked by Wall St. Rank held Rennova Health, Inc. as of Q2 2017.

Based on Citigroup's 13F filing for Q2 2017, filed 11 Aug 2017.